1. Medline's IPO raised $6.26 billion, marking the largest IPO in four years. 2. Shares surged over 41% post-IPO, opening at $35 above $29 pricing. 3. Cramer suggests waiting for a price drop to $29 or $30 before buying. 4. Private equity shareholders' potential cash-out may pressure stock prices long-term. 5. Current valuation at 45 times earnings is considered high for modest growth.
FAQ
Why Bearish?
High valuation and private equity pressures may limit short-term upside.
How important is it?
The article outlines risks related to valuation and shareholder composition, impacting investor sentiment.
Why Long Term?
Private equity's liquidation strategy could depress stock prices over time.